CENTRELLIS Trademark

Trademark Overview

On Friday, February 8, 2019, a trademark application was filed for CENTRELLIS with the United States Patent and Trademark Office. The USPTO has given the CENTRELLIS trademark a serial number of 88977346. The federal status of this trademark filing is REGISTERED as of Tuesday, March 2, 2021. This trademark is owned by Mount Sinai Genomics, Inc.. The CENTRELLIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a software platform for building predictive models of disease and wellness; providing a software platform for the delivery of test content and interpretations for clinical testing; providing a software platform for the stratification of patient populations to assess risk and match patients to the most effective treatments
centrellis

General Information

Serial Number88977346
Word MarkCENTRELLIS
Filing DateFriday, February 8, 2019
Status700 - REGISTERED
Status DateTuesday, March 2, 2021
Registration Number6284901
Registration DateTuesday, March 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesProviding a software platform for building predictive models of disease and wellness; providing a software platform for the delivery of test content and interpretations for clinical testing; providing a software platform for the stratification of patient populations to assess risk and match patients to the most effective treatments

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 7, 2019
Primary Code042
First Use Anywhere DateThursday, May 30, 2019
First Use In Commerce DateThursday, May 30, 2019

Trademark Owner History

Party NameSEMA4 OPCO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSTAMFORD, CT 06902
Party NameMount Sinai Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10029
Party NameMount Sinai Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10029
Party NameMount Sinai Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10029

Trademark Events

Event DateEvent Description
Wednesday, November 8, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 4, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 2, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, January 28, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 7, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, January 7, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 7, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, January 7, 2021SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, December 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 12, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 12, 2020FINAL REFUSAL E-MAILED
Friday, June 12, 2020SU - FINAL REFUSAL - WRITTEN
Friday, May 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2020NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, April 3, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, March 6, 2020USE AMENDMENT FILED
Friday, April 3, 2020DIVISIONAL PROCESSING COMPLETE
Friday, March 6, 2020DIVISIONAL REQUEST RECEIVED
Friday, April 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 6, 2020TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 6, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, March 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2020SOU EXTENSION 1 GRANTED
Friday, February 28, 2020SOU EXTENSION 1 FILED
Friday, February 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 31, 2019ASSIGNED TO LIE
Friday, May 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 25, 2019NON-FINAL ACTION E-MAILED
Thursday, April 25, 2019NON-FINAL ACTION WRITTEN
Monday, April 22, 2019ASSIGNED TO EXAMINER
Thursday, March 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 12, 2019NEW APPLICATION ENTERED

Related Keywords

centrellis providing platform software assess populations patient risk patients treatments effective